Scale-up of antiretroviral treatment access among people living with HIV in Rivers State, Nigeria, 2019--2020
Andrew T. Boyd, Mahesh Swaminathan(Icahn School of Medicine at Mount Sinai), Golden Owhonda(Rivers State University), Clifford Umeh(Institute of Human Virology), Charles Mensah(Institute of Human Virology), Obinna Ogbanufe, Chibuzor Onyenuobi, Dennis Onotu, Makshwar U. Kumtap(Institute of Human Virology), Patrick Dakum(Institute of Human Virology), Tarfa Verinumbe(Albert Einstein College of Medicine), Solomon Odafe(AIDS Prevention Initiative in Nigeria), Pamela Bachanas, Jerry Gwamna, Chukwuemeka Okolo(Institute of Human Virology), Olayemi Olupitan(Institute of Human Virology), Michelle Williams-Sherlock, Emilio Dirlikov, Ibrahim Jahun, Stanley Idakwo(Institute of Human Virology), Ifunanya Mgbakor(Centers for Disease Control and Prevention), Adeoye Adegboye(Institute of Human Virology), Tedd V. Ellerbrock
Cited by 16
Related Papers
Update: Ongoing Zika Virus Transmission — Puerto Rico, November 1, 2015–July 7, 2016
|MMWR Morbidity and Mortality Weekly Report|2016|118
Environmental Risk Factors for Infection with Mycobacterium avium Complex
|American Journal of Epidemiology|2006|105
Update: Ongoing Zika Virus Transmission — Puerto Rico, November 1, 2015–April 14, 2016
|MMWR Morbidity and Mortality Weekly Report|2016|66
Patients’ demographic and clinical characteristics and level of care associated with lost to follow‐up and mortality in adult patients on first‐line ART in Nigerian hospitals
|Journal of the International AIDS Society|2012|52
Rapid Scale-up of an Antiretroviral Therapy Program Before and During the COVID-19 Pandemic — Nine States, Nigeria, March 31, 2019–September 30, 2020
|MMWR Morbidity and Mortality Weekly Report|2021|22